Frequency Therapeutics, Inc. (FREQ)
NASDAQ: FREQ · IEX Real-Time Price · USD
5.14 -0.05 (-0.96%)
Jan 14, 2022 4:00 PM EST - Market closed
Income Statement (Annual)
Millions USD. Fiscal year is Jan - Dec.
| Year | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|
| Revenue | 36.98 | 28.95 | 0 | 0 |
| Revenue Growth | 27.76% | - | - | - |
| Gross Profit | 36.98 | 28.95 | 0 | 0 |
| Selling, General & Admin | 27.12 | 14.84 | 7.06 | 4.34 |
| Research & Development | 37.42 | 18.78 | 11.88 | 11.97 |
| Other Operating Expenses | 0 | 16 | 0 | 0 |
| Operating Expenses | 64.53 | 49.62 | 18.94 | 16.31 |
| Operating Income | -27.55 | -20.68 | -18.94 | -16.31 |
| Interest Expense / Income | -0.99 | -1.78 | 0.11 | 0.17 |
| Other Expense / Income | -0.08 | -0.15 | 0.12 | 3.76 |
| Pretax Income | -26.48 | -18.75 | -19.17 | -20.24 |
| Income Tax | 0.04 | 0 | 0 | 0 |
| Net Income | -26.51 | -18.75 | -19.17 | -20.24 |
| Preferred Dividends | 0 | 1.05 | 0 | 0 |
| Net Income Common | -26.51 | -19.8 | -19.17 | -20.24 |
| Shares Outstanding (Basic) | 32 | 9 | 2 | 1 |
| Shares Outstanding (Diluted) | 32 | 9 | 2 | 1 |
| Shares Change | 272.90% | 465.23% | 117.70% | - |
| EPS (Basic) | -0.82 | -2.29 | -12.53 | -28.79 |
| EPS (Diluted) | -0.82 | -2.29 | -12.53 | -28.79 |
| Free Cash Flow Per Share | -1.61 | 3.83 | -11.41 | -23.44 |
| Gross Margin | 100.00% | 100.00% | - | - |
| Operating Margin | -74.49% | -71.42% | - | - |
| Profit Margin | -71.68% | -64.76% | - | - |
| Free Cash Flow Margin | -140.22% | 114.53% | - | - |
| Effective Tax Rate | -0.13% | 0.00% | 0.00% | 0.00% |
| EBITDA | -25.89 | -19.72 | -18.41 | -19.53 |
| EBITDA Margin | -70.00% | -68.11% | - | - |
| EBIT | -27.47 | -20.53 | -19.06 | -20.06 |
| EBIT Margin | -74.28% | -70.92% | - | - |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).